Mice with conditional loss of FXN in the heart develop cardiac hypertrophy as early as 5 weeks of age, followed by transition to dilated cardiomyopathy and heart failure by approximately 8 weeks of age [30]. This evidence concerns the gene FXN and dilated cardiomyopathy.